Mr. Alnoor Nathoo reports

MEDBRIGHT AI ANNOUNCES ELECTION OF TWO US HEALTHCARE EXPERTS TO BOARD OF DIRECTORS AND APPROVAL OF NEW SHARE CLASS

Medbright AI Investments Inc. elected two new members to its board of directors, Dr. Jaime Gerber and Dr. Konita Wilks, at the company's annual general and special meeting of shareholders held on Dec. 1, 2023. Dr. Gerber will serve as chairman of the board.

Dr. Gerber, MD, FACC, RPVI, is a cardiologist specializing in preventive cardiology, as well as complex cardiology cases that involve coronary artery disease, peripheral artery disease and risk factor modification. Additionally, Dr. Gerber is a professor of medicine at Yale Medical School, is the co-director of the Yale Executive Health program, and directs the Yale New Haven Heart & Vascular Center laboratory for vascular ultrasound testing for peripheral arterial disease. He has broad experience in medical systems management and health care start-ups.

Dr. Konita Wilks, DDS, applies mission-driven, strategic thinking to improve hospital operations and patient outcomes as the chief executive officer of Olive View-UCLA Medical Center in Los Angeles, Calif., a 355-bed general acute care hospital that employs nearly 5,500 persons and has a $900-million annual operating budget. She has over 25 years of experience as a dynamic, visionary leader in health care and the military. Prior to her role as chief executive officer, she served as the medical director of quality and patient safety officer and chief of dental services for Los Angeles County Health Services. Dr. Wilks is a U.S. Naval Academy graduate, naval officer, and combat veteran who fought in support of Operation Iraqi Freedom and Enduring Freedom in the Persian Gulf. She received her doctorate from the UCLA School of Dentistry.

Michael Dalsin, chairman of the investment committee, says: "Both Dr. Gerber and Dr. Wilks have a proven track record as leaders in health care services. As a large shareholder, I was pleased to see their appointment to the board of directors. Both will be tremendous assets to this organization. I have sought each of their expertise for over 15 years in past endeavours, including my time as chairman of Patient Home Monitoring (PHM.V) which was listed on the TSX-V before spinning out into two companies, VieMed Healthcare (VMD) and Quipt Home Medical (QIPT), which currently trade on the Nasdaq."

Approval of Class A non-voting common shares

The company also announces that the company's shareholders have approved the creation of a new class of Class A non-voting common shares in connection with the company's previously announced transaction with an FDA & HIPPA compliant artificial intelligence platform, AIP, doing business as Limmi, a Delaware corporation named Mentorhead Inc. For a more detailed description of the proposed transaction with Limmi, see the company's news releases dated Sept. 8, 2023 and Oct. 17, 2023.

Once created, the non-voting shares shall have the same attributes as the common shares of the company, except that the non-voting shares will not be listed on the Canadian Securities Exchange, will not carry the right to vote, and will be convertible into common shares on a one-for-one basis, subject to certain conditions, including a prohibition on the holder of non-voting shares from converting such shares into common shares if it would result in such holder holding more than 9.9 per cent of the common shares.

About Medbright AI Investments Inc.

Medbright AI is a capital allocator focused on investing in health care technology companies. The team at Medbright prides itself on unparalleled access to opportunities, as well as structuring unique and advantageous investments. Medbright's mission is to construct a portfolio of synergistic investments to generate superior returns for shareholders. Medbright will focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.

We seek Safe Harbor.